The military's new testosterone policy has doctors asking: Who will manage the fallout?

Defense Secretary Pete Hegseth announced this week that service members aged 30 and older will undergo annual screening for testosterone deficiency as part of their routine medical evaluations.^[]

Troops younger than 30 will be able to opt in, and those found to have low testosterone may choose to receive testosterone replacement therapy (TRT). According to Hegseth, the goal is to optimize readiness, resilience, and long-term health—not to enhance performance beyond normal physiologic levels.

For physicians, the announcement raises a more nuanced question than the political debate surrounding it: Is broad testosterone screening in an otherwise healthy population good medicine?

What was announced?

Although details of the screening protocol have not yet been released, the announcement appears to represent one of the largest organized testosterone screening efforts in the US.

Why this has physicians talking

While TRT has an established role in men with confirmed testosterone deficiency, the concern is whether routine screening of a large population could identify clinically insignificant low testosterone levels that don't represent true endocrine disease.^[]

“This is non-evidence-based and could cause harm,” Adriane Fugh-Berman, MD, told the Washington Post.^[]

In a thread on r/medicine, clinicians across specialties weighed in on Hegseth's announcement and shared their concerns about the feasibility of across-the-board hormone testing.

Reddit user @loveleathershoes, an endocrinologist, writes: "This is hilarious. Wonder what cutoffs they will use to define a 'normal' testosterone level. I can foresee many a case of secondary male hypogonadism due to prolonged and inappropriate use of testosterone."

"Great. Just great," writes primary care physician @terracottatilefish. "This will do fantastic things for the large number of men already coming to me convinced that their T is low and then going to some online men's clinic to get testosterone when I tell them that their levels are normal and they need a sleep study."

Low testosterone is a diagnosis—not just a laboratory result

Current endocrine and urologic guidelines generally recommend diagnosing testosterone deficiency only when patients present with both compatible clinical symptoms or signs and consistently low morning serum testosterone confirmed on repeat testing.^[]

Many of these complaints, however, are nonspecific and overlap with depression, sleep disorders, obesity, chronic illness, medication effects, and overtraining. That diagnostic complexity is one reason many specialists are cautious about population-wide screening.

TRT isn't risk-free

Physicians familiar with testosterone prescribing know that initiating therapy is rarely the end of the conversation.

Patients require ongoing monitoring for heart problems, edema, worsening of sleep apnea, severe mood changes, difficulty urinating or noticeable changes in urinary patterns, or signs of allergic reaction.^[]

What patients may start asking

Even physicians who never care for military personnel may soon notice an increase in questions from patients.

News coverage of the Pentagon initiative may reinforce growing public interest in testosterone optimization, fueled by wellness clinics, social media influencers, and direct-to-consumer telehealth companies.

Those conversations create an opportunity to review evidence-based indications for testing—and to remind patients that fatigue, weight gain, low libido, and reduced exercise performance often have multifactorial causes.